Instituto de Assistência Médica ao Servidor Público Estadual is an economically self-sufficient governmental health system in the Brazilian State of São Paulo that attends to the health needs of state government employees, their families, and dependents.

During the past decade, Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 7 clinical trials were completed, i.e. on average, 21.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 6 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE" #1 sponsor was "Janssen Research & Development, LLC" with 11 trials, followed by "Hospital do Servidor Publico Estadual" with 7 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Abbott" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "University of Sao Paulo" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE" are "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (3 trials), "Crohn Disease" (3 trials), "HIV Infections" (3 trials) and "Deep Venous Thrombosis" (2 trials). Many other conditions were trialed in "Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE" in a lesser frequency.

Most popular intervention types in "Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE" are "Drug" (37 trials), "Procedure" (5 trials), "Biological" (3 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Etrolizumab" (4 trials), "Guselkumab" (3 trials), "Prednisone" (3 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE" are 44 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE". 2 are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 8 trials that are defined as “Not Applicable".

Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE has several departments that took part in Clinical trials: "Hospital Estadual do Servidor Publico; Hematologia" - 2 trials